[旁路手术中静脉直径的改善:超柔性生物复合移植物在患者中的初步应用]。

Swiss surgery. Supplement Pub Date : 1996-01-01
H R Zurbrügg, H Zirngibl
{"title":"[旁路手术中静脉直径的改善:超柔性生物复合移植物在患者中的初步应用]。","authors":"H R Zurbrügg,&nbsp;H Zirngibl","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The use of varicose-ectatically altered veins in bypass surgery is unsatisfactory due to unfavorable flow dynamics and high closure rates. To date surgical repair possibilities to improve the flow profile of autologous vein bypasses have been limited. Using the patient's own veins to produce a biocompound graft, i.e. an ultraflexible hybrid prosthesis, is a simple method by which the surgeon can influence the profile and wall pressure of the bypass. The authors hope thus to improve the patency rate. When forming a biocompound graft, a vein is intraoperatively sheathed inside a fine ultraflexible metal mesh and the two joined with fibrin glue. The mesh hose is pulled over the entire length of the vein with the aid of an application set. Biocompound grafts were used as aorto-coronary bypasses in 9 patients (5 women, 4 men) in whom the possibility of using alternative bypasses did not exist. In 2 patients with femoro-popliteal bypass procedure the autologous varicose-ectatically altered vein was used as a biocompound-graft. Aorto-coronary bypasses: at the time of discharge from the hospital all biocompound bypasses were patent. No perioperative myocardial infarctions were observed. No wound infections occurred. Femoro-popliteal bypasses: at time of discharge from the hospital all biocompound bypasses were patent. The results prove the simplicity and reliability of this method in difficult surgical cases. The biocompound graft offers the surgeon the possibility of using varicose-ectatic veins if alternative bypasses are not available.</p>","PeriodicalId":79460,"journal":{"name":"Swiss surgery. Supplement","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Improvement of venous diameter in bypass surgery: initial applications of ultraflexible biocompound grafts in patients].\",\"authors\":\"H R Zurbrügg,&nbsp;H Zirngibl\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The use of varicose-ectatically altered veins in bypass surgery is unsatisfactory due to unfavorable flow dynamics and high closure rates. To date surgical repair possibilities to improve the flow profile of autologous vein bypasses have been limited. Using the patient's own veins to produce a biocompound graft, i.e. an ultraflexible hybrid prosthesis, is a simple method by which the surgeon can influence the profile and wall pressure of the bypass. The authors hope thus to improve the patency rate. When forming a biocompound graft, a vein is intraoperatively sheathed inside a fine ultraflexible metal mesh and the two joined with fibrin glue. The mesh hose is pulled over the entire length of the vein with the aid of an application set. Biocompound grafts were used as aorto-coronary bypasses in 9 patients (5 women, 4 men) in whom the possibility of using alternative bypasses did not exist. In 2 patients with femoro-popliteal bypass procedure the autologous varicose-ectatically altered vein was used as a biocompound-graft. Aorto-coronary bypasses: at the time of discharge from the hospital all biocompound bypasses were patent. No perioperative myocardial infarctions were observed. No wound infections occurred. Femoro-popliteal bypasses: at time of discharge from the hospital all biocompound bypasses were patent. The results prove the simplicity and reliability of this method in difficult surgical cases. The biocompound graft offers the surgeon the possibility of using varicose-ectatic veins if alternative bypasses are not available.</p>\",\"PeriodicalId\":79460,\"journal\":{\"name\":\"Swiss surgery. Supplement\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Swiss surgery. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss surgery. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

由于不利的血流动力学和高闭合率,在搭桥手术中使用曲张改变的静脉是不令人满意的。迄今为止,外科修复改善自体静脉旁路血流轮廓的可能性有限。利用患者自己的静脉制造生物复合移植物,即超柔性混合假体,是一种简单的方法,外科医生可以通过这种方法影响旁路的轮廓和壁压。作者希望以此来提高手术的通畅率。当形成生物复合移植物时,术中将静脉包裹在一个精细的超柔性金属网中,并用纤维蛋白胶将两者连接起来。在应用装置的帮助下,将网状软管拉过整个静脉长度。9例患者(5名女性,4名男性)采用生物化合物移植物作为主动脉-冠状动脉旁路,其中不存在使用其他旁路的可能性。在2例行股腘静脉搭桥手术的患者中,采用自体曲张改变静脉作为生物复合移植物。主动脉-冠状动脉旁路:出院时所有的生物化合物旁路都是专利的。围手术期未见心肌梗死。无伤口感染发生。股-腘动脉旁路:出院时所有的生物化合物旁路都是通畅的。结果表明,该方法简便、可靠,适用于外科疑难病例。如果没有其他的旁路手术,生物复合移植物为外科医生提供了使用曲张扩张静脉的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Improvement of venous diameter in bypass surgery: initial applications of ultraflexible biocompound grafts in patients].

The use of varicose-ectatically altered veins in bypass surgery is unsatisfactory due to unfavorable flow dynamics and high closure rates. To date surgical repair possibilities to improve the flow profile of autologous vein bypasses have been limited. Using the patient's own veins to produce a biocompound graft, i.e. an ultraflexible hybrid prosthesis, is a simple method by which the surgeon can influence the profile and wall pressure of the bypass. The authors hope thus to improve the patency rate. When forming a biocompound graft, a vein is intraoperatively sheathed inside a fine ultraflexible metal mesh and the two joined with fibrin glue. The mesh hose is pulled over the entire length of the vein with the aid of an application set. Biocompound grafts were used as aorto-coronary bypasses in 9 patients (5 women, 4 men) in whom the possibility of using alternative bypasses did not exist. In 2 patients with femoro-popliteal bypass procedure the autologous varicose-ectatically altered vein was used as a biocompound-graft. Aorto-coronary bypasses: at the time of discharge from the hospital all biocompound bypasses were patent. No perioperative myocardial infarctions were observed. No wound infections occurred. Femoro-popliteal bypasses: at time of discharge from the hospital all biocompound bypasses were patent. The results prove the simplicity and reliability of this method in difficult surgical cases. The biocompound graft offers the surgeon the possibility of using varicose-ectatic veins if alternative bypasses are not available.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信